Fidelity Investments
LUNG icon

Fidelity Investments’s Pulmonx LUNG Stock Holding History

Fidelity Investments’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.4K Sell
35,728
-12,494
-26% -$17.2K ﹤0.01% 4338
2026
Q1 		$62.2K Sell
48,222
-26,980
-36% -$44.6K ﹤0.01% 4013
2025
Q4 		$166K Sell
75,202
-2,099,156
-97% -$3.95M ﹤0.01% 3520
2025
Q3 		$3.52M Sell
2,174,358
-2,087,010
-49% -$4.37M ﹤0.01% 2346
2025
Q2 		$11M Sell
4,261,368
-1,156,888
-21% -$4.56M ﹤0.01% 1896
2025
Q1 		$36.5M Sell
5,418,256
-504,926
-9% -$3.58M ﹤0.01% 1477
2024
Q4 		$40.2M Buy
5,923,182
+50,300
+0.9% +$331K ﹤0.01% 1466
2024
Q3 		$48.7M Buy
5,872,882
+591,859
+11% +$4.28M ﹤0.01% 1383
2024
Q2 		$33.5M Buy
5,281,023
+427,088
+9% +$3.28M ﹤0.01% 1469
2024
Q1 		$45M Buy
4,853,935
+1,544,434
+47% +$18.1M ﹤0.01% 1366
2023
Q4 		$42.2M Buy
3,309,501
+1,279,666
+63% +$13.3M ﹤0.01% 1356
2023
Q3 		$21M Buy
2,029,835
+401,830
+25% +$4.65M ﹤0.01% 1569
2023
Q2 		$21.3M Buy
1,628,005
+665,507
+69% +$8.14M ﹤0.01% 1609
2023
Q1 		$10.8M Buy
962,498
+927,223
+2,629% +$9.15M ﹤0.01% 1846
2022
Q4 		$297K Sell
35,275
-6,466
-15% -$61.5K ﹤0.01% 2884
2022
Q3 		$695K Buy
41,741
+564
+1% +$10.4K ﹤0.01% 2689
2022
Q2 		$606K Sell
41,177
-281
-0.7% -$5.79K ﹤0.01% 2789
2022
Q1 		$1.03M Sell
41,458
-439,796
-91% -$11.4M ﹤0.01% 2784
2021
Q4 		$15.4M Sell
481,254
-3,531
-0.7% -$129K ﹤0.01% 1938
2021
Q3 		$17.4M Buy
484,785
+203,217
+72% +$8M ﹤0.01% 1899
2021
Q2 		$12.4M Sell
281,568
-198,292
-41% -$8.63M ﹤0.01% 2021
2021
Q1 		$21.9M Sell
479,860
-95,104
-17% -$5.45M ﹤0.01% 1761
2020
Q4 		$39.7M Buy
+574,964
New +$28.2M ﹤0.01% 1413

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Fidelity Investments's LUNG Position: Q2 2026 in Review

Fidelity Investments reduced its Pulmonx (LUNG) stake by 26% in Q2 2026, selling an estimated $17.2K and leaving 35,728 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4338.

Fidelity Investments first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $48.7M in Q3 2024. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Fidelity Investments held 35,728 shares of Pulmonx worth $46.4K as of Q2 2026.
  • Fidelity Investments sold 12,494 Pulmonx shares in Q2 2026, an estimated $17.2K.
  • Pulmonx made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4338 holding.
  • Fidelity Investments first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Fidelity Investments's Pulmonx position peaked at $48.7M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.